Pyridoxamine doesn't slow progression of diabetic nephropathy

10/30/2011 | Medscape (free registration)

Treatment with pyridoxamine, a vitamin b6 derivative, did not show significant effects in serum creatinine levels in type 2 diabetes patients with advanced renal disease, according to a study in the Journal of the American Society of Nephrology. However, the study suggested patients with more mild renal impairment may benefit from the drug, and the researchers said more investigation is needed in this population.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA